Atherosclerosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Meets the diagnostic criteria for lower limb arteriosclerotic occlusive disease (Rutherford Stage 0–1) or atherosclerotic carotid artery disease; voluntarily participates in the study and signs an informed consent form; aged 18–75 years.
Exclusion criteria
Exclusion criteria: (1) Patients who have allergic reactions or other adverse reactions to the trial medication; (2) Patients with blood disorders such as coagulation dysfunction anemia or platelet abnormalities; (3) Patients with a history of bleeding disorders in the past three months; (4) Patients with conditions at high risk of major bleeding such as peptic ulcers malignant tumors esophageal varices arteriovenous malformations or vascular aneurysms; (5) Patients with severe comorbidities such as diabetes heart failure cerebral hemorrhage or abnormal liver or kidney function; (6) Patients with inflammatory vascular diseases such as thromboangiitis obliterans Takayasu arteritis or Raynaud's syndrome; (7) Pregnant or breastfeeding women; (8) Patients with psychiatric disorders; (9) Patients whom the investigator deems to have poor compliance and are unlikely to cooperate with the treatment; (10) Patients with incomplete medical records.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum TNF-a level; | — |
Secondary
| Measure | Time frame |
|---|---|
| blood lipid level;Serum VCAM-1 level;Serum P-selectin level;Serum IL-1ß level;Serum ICAM-1 level;Serum I?Ba level;Serum E-selectin level;Serum NF-?B p65 level; | — |
Countries
China
Contacts
Guang'anmen Hospital Jinan Hospital China Academy of Chinese Medical Sciences